Predictivemarkers of endoscopic remission at 12 months of therapy in mild-to-moderate ulcerative colitis
https://doi.org/10.33878/2073-7556-2025-24-4-80
References
1. Turner D, Ricciuto A, Lewis A et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570–1583.
2. Singh S, Loftus E Jr, Limketkai B. et al. Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2024 Dec;167(7):1307–1343.
Review
For citations:
Predictivemarkers of endoscopic remission at 12 months of therapy in mild-to-moderate ulcerative colitis. Koloproktologia. 2025;24(4):80. (In Russ.) https://doi.org/10.33878/2073-7556-2025-24-4-80
Views:
7
Email this article 
